| Catalog Number |
405733 |
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
09/26/2018
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Pma/510(k)#: enforcement discretion.A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.
|
| |
|
Event or Problem Description
|
|
It was reported that bd¿ spinal tray was missing label information.No serious injury or medical intervention was reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Investigation summary: no samples were provided for evaluation.However, the bupivacaine and marcaine drug components were intentionally removed per an internal project due to supply chain disruption.Based on the complaint investigation results, no probable root cause associated with the manufacturing process was identified.Since no probable root cause was identified, no corrective and/or preventive actions were identified for this complaint.This complaint will be added to the complaint management system and will be tracked & trended for future occurrences through the quality data analysis process.A review of the device history record shows that all inspection results passed per the dhr process and no anomalies were noticed during production.The review also noted that lot 0001253521 was manufactured per a project without the bupivacaine and marcaine drug components due to supply chain disruptions with the vendor.
|
| |
|
Event or Problem Description
|
|
It was reported that bd¿ spinal tray was missing label information.No serious injury or medical intervention was reported.
|
| |
|
Search Alerts/Recalls
|